Estimate Recalculated Nov 1, 2024 02:19PM EST
Ronald C Renaud Jr has an estimated net worth of $18.7 Million. This is based on reported shares across multiple companies, which include Atara Biotherapeutics, Inc., CHIMERIX INC, Ikena Oncology, Inc., PTC THERAPEUTICS, INC., Translate Bio, Inc., Akebia Therapeutics, Inc., Cerevel Therapeutics Holdings, Inc., IDENIX PHARMACEUTICALS INC, and KERYX BIOPHARMACEUTICALS INC.
Ronald C Renaud Jr's CIK is 0001354434
2021 was Ronald C Renaud Jr's most active year for acquiring shares with 8 total transactions. Ronald C Renaud Jr's most active month to acquire stocks was the month of May. 2014 was Ronald C Renaud Jr's most active year for disposing of shares, totalling 11 transactions. Ronald C Renaud Jr's most active month to dispose stocks was the month of July. 2015 saw Ronald C Renaud Jr paying a total of $612,000.00 for 26,000 shares, this is the most they've acquired in one year. In 2021 Ronald C Renaud Jr cashed out on 3,037,927 shares for a total of $19,122,778.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!